Clinical Study
Long-Term Observation of Triplex Surgery for Cataract after Phakic 6H Implantation for Super High Myopia
Table 1
Baseline clinical data before and after phakic 6H AC pIOL implantation in eyes that developed cataract and underwent the triplex surgery.
| Case/eye | Sex/age (y) |
AL (mm) | ACD (mm) | CCT (µm) | WTW (mm) | SE |
Phakic 6H AC pIOL |
ECD (cells/mm2) | BCVA (logMAR) | Time between PSR surgery and phakic 6H implantation (y) | Time between phakic 6H implantation and triplex surgery (y) | Pre | Post | Power | Optic diameter (mm) | Pre | Post (6 m) | Pre | Post |
| 1/R | F/42 | 31.94 | 3.62 | 501 | 11.3 | −21.50 | −2.00 | −19.50 | 12.5 | 2852 | 2530 | 0.52 | 0.30 | 3.0 | 6.5 | 1/L | | 31.64 | 3.34 | 497 | 11.3 | −21.50 | −1.50 | −19.50 | 12.5 | 2709 | 2451 | 0.52 | 0.30 | 3.0 | 6.5 | 2/R | F/35 | 31.04 | 3.52 | 510 | 11.9 | −15.00 | −0.50 | −14.00 | 12.5 | 2403 | 2103 | 0.10 | 0.10 | None | 6.0 | 2/L | | 30.67 | 3.38 | 492 | 11.8 | −14.00 | −1.25 | −13.00 | 12.5 | 2050 | 2100 | 0.22 | 0.22 | None | 6.0 | 3/R | F/38 | 29.09 | 3.70 | 519 | 12.0 | −15.50 | +0.50 | −15.50 | 13.0 | 2698 | 2579 | 0.15 | 0.00 | 5.0 | 7.0 | 3/L | | 31.13 | 3.67 | 507 | 11.7 | −20.50 | −0.75 | −19.50 | 12.5 | 2543 | 2541 | 0.40 | 0.22 | 5.0 | 7.0 | 4/R | F/47 | 31.09 | 3.58 | 507 | 12.1 | −15.50 | +0.50 | −15.00 | 13.0 | 2954 | 2705 | 0.05 | 0.00 | 1.5 | 7.0 | 4/L | | 29.75 | 3.74 | 513 | 12.1 | −13.75 | −1.00 | −13.50 | 13.0 | 3010 | 2828 | 0.00 | 0.00 | 1.5 | 7.8 | 5/L | F/45 | 33.75 | 3.62 | 558 | 12.7 | −18.50 | −2.25 | −17.50 | 13.5 | 2922 | 2749 | 0.15 | 0.00 | None | 8.3 | 6/R | F/39 | 32.51 | 3.66 | 554 | 11.6 | −25.00 | 0.00 | −23.50 | 12.5 | 2322 | 2545 | 0.52 | 0.22 | 7.5 | 8.3 | 6/L | | 32.39 | 3.89 | 546 | 11.6 | −27.00 | −0.75 | −23.50 | 12.5 | 2900 | 2708 | 0.52 | 0.22 | 7.5 | 6.3 | 7/R | M/44 | 33.72 | 3.89 | 527 | 11.8 | −22.00 | −0.25 | −19.00 | 12.5 | 2373 | 2384 | 1.30 | 0.70 | None | 4.0 | 8/R | F/31 | 32.59 | 3.53 | 589 | 11.5 | −22.75 | −1.00 | −21.00 | 12.5 | 2734 | 2699 | 0.40 | 0.30 | None | 5.5 | 8/L | | 32.41 | 3.54 | 574 | 11.4 | −22.00 | −0.75 | −20.50 | 12.5 | 3195 | 3058 | 0.40 | 0.30 | None | 5.8 | 9/L | F/27 | 31.58 | 3.18 | 537 | 11.4 | −26.00 | −3.00 | −22.00 | 12.5 | 2769 | 2681 | 0.70 | 0.70 | None | 5.0 | 10/L | F/37 | 30.73 | 3.62 | 540 | 11.6 | −19.00 | 0.00 | −18.00 | 12.5 | 2730 | 2486 | 0.82 | 0.40 | 6.5 | 8.3 | Mean (SD) | 38.5 (6.3) | 31.63 (1.28) | 3.59 (0.19) | 529 (29) | 11.7 (0.4) | −19.97 (4.27) | −0.89 (0.95) | −18.41 (3.40) | 12.7 (0.3) | 2698 (296) | 2572 (245) | 0.42 (0.33) | 0.25 (0.22) | 4.5 (2.4) | 6.6 (1.2) |
|
|
AL: axial length; ACD: anterior chamber depth (including corneal thickness); CCT: central corneal thickness; WTW: white to white; SE: spherical equivalent; Pre: before phakic 6H AC pIOL implantation; Post: after phakic 6H AC pIOL implantation; ECD: endothelial cell density; BCVA: best corrected visual acuity; SE: spherical equivalent; PSR: posterior scleral reinforcement surgery; m: month(s).
|